The JCO Podcast hosted by Dr. Shannon Westin features discussions of new and noteworthy results published in ASCO’s Journal of Clinical Oncology.
…
continue reading
JCO Oncology Practice (JCO OP) provides oncologists and other oncology professionals with information and tools to enhance practice efficiency and promote a high standard for quality of patient care. The goal of JCO OP is to be the authoritative resource on clinical and administrative management for practicing oncologists. The Journal includes original research, feature articles, and section columns on various issues pertinent to daily practice operations, all of which are subject to peer re ...
…
continue reading
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
…
continue reading
Discussions of timely topics in clinical medicine, biomedical research, public health, health policy, and more, featured in the Medical News section of JAMA, the Journal of the American Medical Association.
…
continue reading
The latest clinical medicine and health policy news for healthcare professionals, delivered each weekday by host Nick Andrews and MDedge editors. The information in this podcast is provided for informational and educational purposes only.
…
continue reading
The Video Journal of Oncology (VJOncology) podcast covers the latest solid oncology news from international experts, including breast, lung, skin, genitourinary, head and neck, gynecological and more. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjoncology.com
…
continue reading
Oncology On The Go is a biweekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY. Each episode, you'll hear from one of the authors of our featured article to summarize the important takeaways from that piece. Then, an outside expert will give their perspective on the details of that article. As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematology through review articles, news, podcasts, ...
…
continue reading
Oncology News and Views from Photon Media. For more info, please visit photonmedia.org.
…
continue reading
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us ...
…
continue reading
The Oncology Podcast including Supportive Care Matters by Dr. Bogda Koczwara, are brought to you by The Oncology Network. The Oncology Network are producers of digital resources that support busy oncology health professionals. For more information visit our website www.oncologynews.com.au. We also invite Healthcare Professionals to subscribe to The Oncology Newsletter and our Oncology Portal for free and exclusive resources at: www.oncologynetwork.com.au
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Hemophilia updates from ISTH 2024: ongoing clinical trials, emerging gene therapies & remaining challenges
18:41
18:41
Play later
Play later
Lists
Like
Liked
18:41
This week's VJHemOnc podcast brings you updates in hemophilia from the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Bangkok, Thailand, and virtually. You hear from experts Omolade Awodu, MBChB, MD, FMCPath, University of Benin, Benin City, Nigeria, who discusses key hemophilia clinical trials in 2024, Rad…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep123: Optimizing Benefits Following Dostarlimab Approval in Endometrial Cancer
10:56
10:56
Play later
Play later
Lists
Like
Liked
10:56
CancerNetwork® spoke with Ritu Salani, MD, about the expanded FDA approval of dostarlimab-gxly (Jemperli) in combination with carboplatin/paclitaxel for patients with primary advanced or recurrent endometrial cancer.1 Salani, a board-certified gynecologic oncologist and director of Gynecologic Oncology at the University of California, Los Angeles H…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Highlights From the Alzheimer’s Association International Conference
21:32
21:32
Play later
Play later
Lists
Like
Liked
21:32
Sebastian Palmqvist, MD, PhD, and Wiesje van der Flier, PhD, cochairs of the 2024 Alzheimer’s Association International Conference, speak with JAMA Medical News Lead Senior Staff Writer Rita Rubin, MA, about highlights from the annual meeting, including a blood test for Alzheimer disease, repurposing of a GLP-1 receptor agonist, and the possible br…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Oncology Journal Club Episode 8: Older Patients, Endometrial Cancer, Sarcoma in Brazil and much more
39:07
39:07
Play later
Play later
Lists
Like
Liked
39:07
Send us a Text Message. Curious about the latest breakthroughs in oncology treatment? Prepare to have your perspective shifted and hopefully a few laughs too, as we dissect the most compelling research and clinical insights with our expert hosts, Professor Craig Underhill, Dr. Kate Clarke, and Professor Christopher Jackson. Today’s episode covers a…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
318: Drug pricing drops & psychedelics under fire
21:16
21:16
Play later
Play later
Lists
Like
Liked
21:16
STAT’s chief Washington correspondent Rachel Cohrs Zhang joins us to discuss the discounts and how this first round of negotiations between pharmaceutical companies and Medicare officials played out. After that, we chat with our colleague Meghana Keshavan about the latest news in the psychedelics world, including the retraction of three research pa…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Inflammation and immune interventions in MDS: targeting STAT, IRAK4, & more
17:29
17:29
Play later
Play later
Lists
Like
Liked
17:29
In myelodysplastic syndromes (MDS), chronic inflammation driven by the innate immune system plays a key role in disease progression. Signal Transducer and Activator of Transcription (STAT) and Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) are critical mediators in this process, where dysregulated signaling leads to aberrant hematopoiesis and t…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep122: Taking a “Cross-Cutting Approach” With Cancer Vaccinations
13:49
13:49
Play later
Play later
Lists
Like
Liked
13:49
In a conversation with CancerNetwork®, Catherine J. Wu, MD, spoke about the ongoing development of cancer vaccines as a potentially “cross-cutting” therapeutic strategy for treating patients with cancer. Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies and a Lavine Family Chair for Preventative Cancer Therapies at Dana-…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Social Media Needs Warning Labels: Q&A With Surgeon General Vivek H. Murthy, MD, MBA
17:32
17:32
Play later
Play later
Lists
Like
Liked
17:32
Social media is the focus of the US surgeon general's conversation with JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. She interviews Vivek H. Murthy, MD, MBA, to discuss the dangers of social media on youth mental health, highlighting its contribution to the epidemic of loneliness. This is part 2 of a 2-part Q&A. Related Content: US S…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Advancements in precision medicine for colorectal cancer
5:56
5:56
Play later
Play later
Lists
Like
Liked
5:56
In this week’s podcast, we will be covering recent updates and integrating precision medicine for the treatment of colorectal cancer. We’ll be covering a wide range of topics including biomarker-driven treatments, challenges in using minimal residual disease in the clinic and more. Listen to expert insights from Scott Kopetz, The University of Texa…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
317: VC struggles, drug pricing negotiations, & Novo's abrupt Wegovy decision
28:52
28:52
Play later
Play later
Lists
Like
Liked
28:52
STAT's Washington Correspondent John Wilkerson joins us to discuss the first round of drug pricing negotiations under the Inflation Reduction Act, which will wrap up by September 1. We also cover the latest news in the life sciences including the merger of AI drug development companies Recursion Pharmaceuticals and Exscientia, Novo Nordisk's decisi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Multi-Cancer Early Detection Testing for High-Risk Patients
30:29
30:29
Play later
Play later
Lists
Like
Liked
30:29
Host Dr. Davide Soldato interviews Dr. Sana Raoof to discuss the JCO article Turning the Knobs on Screening Liquid Biopsies for High-Risk Populations: Potential for Dialing Down Invasive Procedures. TRANSCRIPT Dr. Davide Soldato: Hello, and welcome to JCO After Hours, the podcast where we sit down with others from some of the latest articles publis…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
iwCAR-T sessions: clinical advances in GI Cancers
23:54
23:54
Play later
Play later
Lists
Like
Liked
23:54
In this podcast, we join leading experts Randy Hecht from UCLA, Diane Simeone from University of California San Diego, and Ben Schechter from Dana-Farber Cancer Institute as they delve into groundbreaking advancements in GI cancer therapies, as presented at the latest iwCAR-T workshop in Miami, Florida. Explore the latest updates and insights on tr…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Updates in the treatment of SCD and thalassemia from EHA 2024: key trial updates, challenges with gene therapies & unmet needs
11:58
11:58
Play later
Play later
Lists
Like
Liked
11:58
Today’s VJHemOnc podcast features experts Rabi Hanna, MD, The Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, Subarna Chakravorty, MBBS, MRCPCH, FRCPath, PhD, King’s College Hospital NHS Foundation Trust, London, UK, and Ali Taher, MD, PhD, FRCP, American University of Beirut Medical Center, Beirut, Lebanon. They discuss key updates in si…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep121: Advancing Pancreatic Cancer Care Through Intraoperative Radiation Therapy
28:08
28:08
Play later
Play later
Lists
Like
Liked
28:08
CancerNetwork® spoke with Kamran Idrees, MD, MSCI, MMHC, FACS; Natalie A. Lockney, MD; and Milad Baradaran, PhD, DABR, about the potential utility of intraoperative radiation therapy (IORT) among patients with pancreatic cancer. The group detailed the design and mechanism, gradual technical advancements, and trial data supporting the application of…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
316: The long journey to make malaria vaccines, and Sarepta's ties with patient advocates
34:15
34:15
Play later
Play later
Lists
Like
Liked
34:15
Andrew Joseph, STAT's Europe correspondent, joins us to talk about his special report on the 40-year quest to develop the world's first malaria vaccines. We also cover the latest news in the biotech industry, including Sarepta Therapeutics' move to censor a patient video, data from a new Duchenne gene therapy, and a campaign by Mount Sinai to stifl…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep120: Improving CAR T-Cell Therapy Monitoring Strategies and Access in Lymphoma
15:37
15:37
Play later
Play later
Lists
Like
Liked
15:37
In a conversation with CancerNetwork®, Nausheen Ahmed, MD, spoke about optimizing monitoring strategies for patients with B-cell non-Hodgkin lymphoma who undergo treatment with CAR T-cell therapy. Ahmed, an associate professor in the Division of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center, discussed…
…
continue reading
![Artwork](/static/images/128pixel.png)
51
JCO Article Insights: Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade
17:27
17:27
Play later
Play later
Lists
Like
Liked
17:27
In this episode of JCO Article Insights, Rohit Singh interviews Dr. Ticiana Leal on the editorial, "Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade." TRANSCRIPT The guests' disclosures can be found in the transcript. Dr. Rohit Singh: Hello and welcome to JCO’s Article Insights. I am your host Rohit Singh and today we will be discu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Unmet treatment needs in MF: managing prefibrotic disease & thrombocytopenia, novel agents & endpoints for clinical trials
16:00
16:00
Play later
Play later
Lists
Like
Liked
16:00
Myelofibrosis (MF) is a chronic myeloproliferative neoplasm (MPN) characterized by bone marrow fibrosis, extramedullary hematopoiesis, and splenomegaly, often resulting in anemia and thrombocytopenia. There are many unmet treatment needs that remain in this space. This week’s podcast features a discussion from the International Workshop on Myelodys…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
iwCAR-T sessions: cell therapies for melanoma and sarcomas
10:09
10:09
Play later
Play later
Lists
Like
Liked
10:09
In this week’s podcast, we join experts Allison Betof Warner from Stanford Medicine, Amod Sarnaik from Moffitt Cancer Center, and Elizabeth Loggers from Fred Hutchinson Cancer Center on transformative innovations in cell therapies for melanoma and sarcomas, as presented at the most recent iwCAR-T workshop in Miami, Florida. Discover the latest upda…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Clinical Highlights From the American Diabetes Association’s Scientific Sessions
18:52
18:52
Play later
Play later
Lists
Like
Liked
18:52
Endocrinologist Robert Gabbay, MD, PhD, the ADA’s chief scientific and medical officer, speaks with JAMA Medical News about clinical research highlights from the annual meeting, including some of the latest data on blockbuster weight loss medications, “game-changing” diabetes technologies, and a new use for a familiar drug. Related Content: New Dat…
…
continue reading
Which Variant Will Updated COVID-19 Vaccines Target This Fall? COVID-19 May Protect Against the Common Cold Related Content: Picking the Optimal Variant to Target in Updated COVID-19 Vaccines Is Tricky COVID-19 May Protect Against the Common Cold—Here’s Why Knowing That Could Lead to Better Vaccines
…
continue reading
![Artwork](/static/images/128pixel.png)
1
315: UnitedHealth's doctor empire, an FDA departure, and Viking's obesity moves
32:46
32:46
Play later
Play later
Lists
Like
Liked
32:46
What makes UnitedHealth similar to Standard Oil? Is Viking Therapeutics an attractive acquisition target? And is Adam good at math? We discuss all that and more in this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. Tara Bannow, our hospitals and insurance reporter, joins us to talk about a new investigation that shows how UnitedHeal…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
“Cambrian Explosion of Radiotracers”: In Conversation With Sam and Sean From RefleXion
58:59
58:59
Play later
Play later
Lists
Like
Liked
58:59
The Accelerators (Drs. Matt Spraker and Simul Parikh) host Sam Mazin, Ph.D. and Sean Shirvani, MD, CTO and CMO of RefleXion. This Rad Onc startup have created a linear accelerator with on board PET/CT. This allows for SCINTIX biology-guided radiotherapy for bone and lung disease. Sam and Sean join the show to share their story in medical entreprene…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Movement Medicine: Exercise Interventions in Cancer Care
26:34
26:34
Play later
Play later
Lists
Like
Liked
26:34
Send us a Text Message. Welcome to the latest episode of Supportive Care Matters. Join Medical Oncologist Professor Bogda Koczwara AM and Dr. David Mizrahi, Exercise Physiologist and Research Fellow at the Daffodil Center, University of Sydney. Learn how precisely prescribed exercise can transform not just the physical health but also the clinical …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep119: Exploring New Possibilities in Kidney Cancer Detection and Therapy
9:57
9:57
Play later
Play later
Lists
Like
Liked
9:57
At the 2024 Kidney Cancer Research Summit (KCRS), CancerNetwork® spoke with various experts in the kidney cancer field about potential advancements in disease detection and updated efficacy data on immunotherapy and other treatment strategies in patients with renal cell carcinoma (RCC). Karl Semaan, MD, MSc, a postdoctoral oncology research fellow …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The role of BTK inhibitors in MCL, ongoing trials & future outlooks: updates from EHA 2024
12:13
12:13
Play later
Play later
Lists
Like
Liked
12:13
The introduction of Bruton's tyrosine kinase (BTK) inhibitors into the treatment landscape for mantle cell lymphoma (MCL) has transformed the field and provided patients with a promising therapeutic option. In this podcast, you will hear from leading experts who discuss the value of these agents in MCL, sharing updates from EHA 2024. Tune in as Man…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Q&A With Surgeon General Vivek H. Murthy, MD, MBA: Gun Violence Is a Public Health Crisis
13:55
13:55
Play later
Play later
Lists
Like
Liked
13:55
This is a 2-part Q&A series with the US Surgeon General. In part 1, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Vivek H. Murthy, MD, MBA, to discuss the issue of gun violence as a pressing public health crisis and the critical role of public health leadership in combating this issue. Related Content: US Surgeon General Vi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
iwCAR-T sessions: Advances in breast and gynecological cancers
23:34
23:34
Play later
Play later
Lists
Like
Liked
23:34
In this week’s episode, we join Jennifer Specht from Fred Hutchinson Cancer Center, Saurabh Garg from Moffitt Cancer Center, and Rizwan Romee from Dana-Farber Cancer Institute on pioneering advancements in CAR-T cell therapies for breast and gynecological cancers, as discussed at the recent 6th annual iwCAR-T workshop in Miami, Florida. Tune in to …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
314: JD Vance's biotech ties, Cassava resignations, and insulin shortages
33:02
33:02
Play later
Play later
Lists
Like
Liked
33:02
Our Washington correspondent Sarah Owermohle joins us to talk about how JD Vance, Donald Trump's newly announced running mate, could influence health policy if Trump wins the election. We also discuss the latest news in the biopharma industry, including the latest developments in the ongoing controversy surrounding Cassava’s Alzheimer’s drug, short…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep118: Overcoming Physical and Social Barriers in the Lymphoma Field
19:14
19:14
Play later
Play later
Lists
Like
Liked
19:14
As part of the Breaking Barriers: Women in Oncology program, CancerNetwork® spoke with Julie M. Vose, MD, MBA, and Avyakta Kallam, MD, about the evolution of their careers in the hematology-oncology space, including some of the critical advances and challenges associated with their work in the lymphoma field. Vose is division chief, Neumann M. and …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Novel developments in lower-risk MDS & important practical considerations when treating patients
51:42
51:42
Play later
Play later
Lists
Like
Liked
51:42
In today’s VJHemOnc podcast, we will be sharing novel developments in lower-risk myelodysplastic syndromes (LR-MDS) and important practical considerations when treating patients. You will hear from experts Amer Zeidan, MBBS, Yale University and Yale Cancer Center, New Haven, CT, Rena Buckstein, MD, FRCPC, Odette Cancer Research Program, Sunnybrook …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
iwCAR-T sessions: clinical advances in lung cancer
14:15
14:15
Play later
Play later
Lists
Like
Liked
14:15
Welcome to another episode of VJOncology! In this episode, we dive into cutting-edge CAR-T cell therapies for the management of lung cancers, discussed at the sixth International Workshop on CAR-T in Miami, Florida. Join Julian Molina from the Mayo Clinic, Ben Creelan from Moffitt Cancer Center, and Adam Schoenfeld from Memorial Sloan Kettering Can…
…
continue reading
Nora Disis, MD, editor in chief of JAMA Oncology and a JAMA deputy editor, and guests share JAMA Network highlights from the American Society of Clinical Oncology’s annual meeting, including new research on colorectal cancer screening, an antibody therapy for non–small cell lung cancer, access to oncology clinical trials, and a new model of palliat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
313: Biotech layoffs, founder-focused VC, & a big pharma exit
34:52
34:52
Play later
Play later
Lists
Like
Liked
34:52
STAT's West Coast biotech reporter Jonathan Wosen joins "The Readout LOUD" to discuss what’s driving workforce cuts. Plus, entrepreneurs Alexis Borisy and Zach Weinberg call in to discuss their biotech incubator Curie.Bio and how they hope to “free the founders.” We also discuss a big change in Pfizer’s leadership and the debate over a new side eff…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Functional Disability Among US Cancer Survivors
16:12
16:12
Play later
Play later
Lists
Like
Liked
16:12
Dr. Shannon Westin and her guest, Dr. Chao Cao, discuss the paper "Prevalence and Cancer-Specific Patterns of Functional Disability Among US Cancer Survivors, 2017-2022" recently published in the JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Dr. Shannon Westin: Hello, everyone, and welcome to another episode of JC…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Updates on the use of BCMA-targeting bispecific antibodies in R/R multiple myeloma: insights from EHA & ASCO 2024
16:18
16:18
Play later
Play later
Lists
Like
Liked
16:18
BCMA-targeting bispecific antibodies treat multiple myeloma by binding to BCMA on malignant plasma cells and directing T-cells to initiate targeted cell killing. This podcast provides updates on the use of BCMA-targeting bispecific antibodies in relapsed/refractory (R/R) multiple myeloma from the 2024 American Society of Clinical Oncology (ASCO) Me…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep117: Epcoritamab Approval Expands Bispecific Use in Follicular Lymphoma
13:01
13:01
Play later
Play later
Lists
Like
Liked
13:01
Tycel Phillips, MD, spoke with CancerNetwork® ahead of the FDA’s accelerated approval of epcoritamab-bysp (Epkinly) for patients with relapsed/refractory follicular lymphoma to discuss how this agent may impact the treatment paradigm. Phillips, an associate professor in the Division of Lymphoma and Department of Hematology & Hematopoietic Stem Cell…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Future of Wearables and Mobile Devices for Patient Care
30:34
30:34
Play later
Play later
Lists
Like
Liked
30:34
Can data from wearable devices and electronic health records enhance quality improvement in health care? In this Q&A, Sachin Kheterpal, MD, MBA, the University of Michigan Medical School Associate Dean for Research Information Technology, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the potential of data from mobile …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Highlights in colorectal cancer at ASCO and ESMO GI 2024
9:42
9:42
Play later
Play later
Lists
Like
Liked
9:42
In this week’s podcast, we will discuss the most recent developments in colorectal cancer from the 2024 ASCO and ESMO Gastrointestinal (GI) Annual Meetings held in Chicago, IL and Munich, Germany respectively. Join us as five renowned experts discuss highly anticipated findings from clinical trials across different colorectal cancer subtypes. Heinz…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep116: Leveraging Artificial Intelligence Evolutions in Prostate Cancer Care
31:49
31:49
Play later
Play later
Lists
Like
Liked
31:49
In a conversation with CancerNetwork®, James B. Yu, MD, MHS, FASTRO, and Julian C. Hong, MD, MS, spoke about their study titled AI Use in Prostate Cancer: Potential Improvements in Treatments and Patient Care, which was published in the May issue of the journal ONCOLOGY®. Yu is a radiation oncologist in the Department of Radiation Oncology at Smilo…
…
continue reading